Merck & Co. and Moderna always knew they would be making headlines in Madrid this week—just not in the way it panned out. | Merck & Co. and Moderna always knew they would be making headlines in Madrid ...

Merck is strengthening its semiconductor manufacturing footprint in South Korea with a new molybdenum production facility designed to accelerate next-generation chip development, secure local supplies ...

A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma ...

Halozyme makes technologies that allow drugs delivered through intravenous infusion, or IV, to instead be given with ...

Merck's Courtney Ronaldo discusses the strategy behind the company's new oncology campaign, its multichannel presence at ESMO ...

Moderna (MRNA) and Merck (MRK) stocks diverged Friday as investors digested the unexpectedly early release of the companies' ...

Leaked data from Moderna Inc. and Merck & Co.’s highly anticipated melanoma vaccine trial has led to a rare disconnect ...

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma ...

Moderna's personalized melanoma vaccine just posted positive late-stage results alongside Merck, yet shares keep sliding ...

Merck CEO Rob Davis joins 'Squawk on the Street' to discuss leaked data of melanoma vaccine trials, the drop off the ...

Merck partners with NVIDIA, Microsoft & Dawn Health to develop innovative model for PSPs for patients with rare tumours: Darmstadt, Germany Friday, October 23, 2026, 09:00 Hrs [IS ...

US pharma major Merck & Co (NYSE: MRK) and US biotech Moderna (Nasdaq: MRNA) have reported detailed Phase III results showing ...